The biotech is floating a fresh issue of its common stock. Certain participants will be sold warrants in lieu of equity. The company aims to raise gross proceeds of roughly $300 million in a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback